Tevogen Bio

United States
Medina, Washington, United States, 07059

Company profile

Tevogen Bio company profile

Tevogen Bio is a clinical-stage biotech company developing curative and preventative treatments to positively impact global public health. Tevogen is developing T cell immunotherapies in virology, oncology, and neurology by utilizing patented precision T cell platform technology. Its current intellectual property portfolio includes several breakthrough cell and gene therapy platforms.

Business identity

Contact email
[email protected]
Phone number
1 877 838-6436
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2020-01-01, Year

Headquarters

Postal code
07059
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
9
Total equity funding
$28M
Last funding
Post IPO Debt / $36M / 2025-08-19
Last equity funding
Post IPO Equity / $14M
Investors
4
Lead investors
2
Founders
1
Articles
157
Exited on
2024-02-15

Founders and investors

Founders

Ryan Saadi

Lead investors

KRHPThe Patel Family

Investors

HMP PartnersKRHPThe Patel Family